RecruitingCerebral VasospasmAneurysmal Subarachnoid Hemorrhage (aSAH)
Registry on NeVa VS for CerebraL VAsospasm ManagemenT in Post SAH PatiEnts
Eligible age
22+ yrs
Accepts
All genders
Locations
13 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
A multi-center, observational registry study intended to assess the HDE-approved NeVa VS cerebral artery dilation device in patients with symptomatic cerebral vasospasm caused by aneurysmal subarachnoid hemorrhage (aSAH)
Sponsor: Vesalio
You may qualify if…
- ✓ 1. Age ≥22
- ✓ 2. Symptomatic cerebral vasospasm secondary to aneurysmal subarachnoid hemorrhage (aSAH) in the internal carotid artery (ICA), middle cerebral artery (MCA), anterior cerebral artery (ACA), posterior cerebral artery (PCA), or basilar artery (BA)
- ✓ 3. Vessel dilation procedure was performed with the NeVa VS
- ✓ 4. Subject or legal representative is able and willing to give informed consent within 3 days (72 hours) post-index procedure
You may not qualify if…
- ✕ None
Where it's recruiting
California
Burbank · Walnut Creek
Connecticut
New Haven
Florida
Miami
Georgia
Marietta
Illinois
Evanston
Iowa
Iowa City
Kentucky
Lexington
Maine
Portland
Minnesota
Rochester
Pennsylvania
Pittsburgh · Wilkes-Barre
Texas
Harlingen · Houston
Utah
Salt Lake City
Source: ClinicalTrials.gov · NCT06893588 · last updated 2026-05-27